Pharmacogenomic approach to identify drug sensitivity in small-cell lung cancer.

Pharmacogenomic approach to identify drug sensitivity in small-cell lung cancer.

There are currently no molecular targeted approaches to treat small-cell lung cancer (SCLC) similar to those used successfully against non-small-cell lung cancer. This failure is attributable to our inability to identify clinically-relevant subtypes of this disease. Thus, a more systematic approach...

Full description

Bibliographic Details
Main Authors: Gary Wildey, Yanwen Chen, Ian Lent, Lindsay Stetson, John Pink, Jill S Barnholtz-Sloan, Afshin Dowlati
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4157793?pdf=render

Internet

http://europepmc.org/articles/PMC4157793?pdf=render

Similar Items